Position in JNJ
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$257,881,753
+$63,814,185 QoQ
Shares Held
1,054,990
+12.5% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Rockefeller Capital Management L.P. holds $1,669,332,547 across 17 Drug Manufacturers - General names. JNJ ranks #2 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
503,731 | $463,316,658 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,054,990 | $257,881,753 | |
| 3 | AMGN |
Amgen Inc
|
643,944 | $226,571,694 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,752,898 | $210,856,097 | |
| 5 | ABBV |
AbbVie Inc.
|
911,994 | $198,349,572 | |
| 6 | AZN |
Astrazeneca PLC
|
473,389 | $93,361,776 | |
| 7 | PFE |
Pfizer Inc
|
1,984,826 | $55,733,911 | |
| 8 | NVO |
Novo Nordisk A S
|
1,433,073 | $52,665,431 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $257,881,753 | 1,054,990 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $194,067,568 | 937,751 | Shares | Defined | 2026-03-17 | |
| 2025-09-30 | $154,337,673 | 832,368 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $119,663,433 | 783,394 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $116,478,054 | 702,352 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $95,890,723 | 663,053 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $111,699,854 | 689,250 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $106,770,170 | 730,502 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $117,182,720 | 740,772 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $110,238,532 | 703,321 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $106,428,023 | 683,326 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $103,711,850 | 626,582 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $91,787,435 | 592,177 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $106,048,823 | 600,333 | Shares | Defined | 2023-03-06 | |
| 2022-09-30 | $94,549,989 | 578,783 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $84,691,261 | 477,107 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $79,701,569 | 449,707 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $81,761,023 | 477,939 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $77,978,174 | 482,837 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $72,443,095 | 439,742 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $62,707,084 | 381,546 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $59,866,878 | 380,397 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $51,380,571 | 345,114 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $49,509,634 | 352,056 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $41,386,987 | 315,618 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||